Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DRRX | US
0.07
4.67%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
11/09/2024
1.57
1.51
1.59
1.43
DURECT Corporation a biopharmaceutical company researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice rats and other laboratory animals. It also develops larsucosterol (DUR-928) an endogenous orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism stress and inflammatory responses and cell death and survival to treat alcohol-associated hepatitis as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition the company offers POSIMIR a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States as well as through a network of distributors in Japan Europe and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino California.
View LessHigh 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
73.0%1 month
86.2%3 months
84.7%6 months
111.2%-
-
9.67
3.19
0.54
-2.48
5.84
-0.46
-24.93M
51.70M
51.70M
-
-156.79
-
4.30
-299.88
19.21
3.98
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.30
Range1M
0.56
Range3M
0.74
Rel. volume
0.88
Price X volume
88.51K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.1059 | 53.36M | -7.11% | n/a | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.4 | 46.10M | 2.19% | n/a | 25.73% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 3.73 | 39.96M | -2.61% | 5.00 | 27.85% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 6.4 | 35.52M | 1.59% | n/a | 1.35% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.2081 | 32.79M | 9.93% | n/a | 5.20% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3745 | 27.81M | 1.77% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 3.92 | 21.36M | -1.51% | n/a | 0.00% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.02 | 20.12M | -2.45% | 0.79 | 22.86% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.3501 | 18.68M | 4.57% | n/a | 81.86% |
Guardion Health Sciences Inc | GHSI | Drug Manufacturers-Specialty & Generic | 10.12 | 12.41M | 3.05% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.22 | 28.90M | 7.33% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.1999 | 21.50M | 3.44% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.51 | 14.54M | -8.48% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.6884 | 9.61M | 5.91% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4111 | 3.80M | 15.03% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.255 | 3.47M | -2.71% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2167 | 2.98M | -7.79% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.59 | 911.88K | -4.79% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.29 | 0 | 0.07% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.48 | - | Cheaper |
Ent. to Revenue | 5.84 | - | Cheaper |
PE Ratio | - | 28.13 | - |
Price to Book | 9.67 | 11.07 | Par |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 84.68 | - | Par |
Debt to Equity | 3.19 | -0.91 | Expensive |
Debt to Assets | 0.54 | 0.45 | Expensive |
Market Cap | 51.70M | - | Emerging |